Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Monocyte-to-macrophage differentiation is a critical event that accentuates atherosclerosis by promoting an inflammatory environment within the vessel wall. In this study, we investigated the molecular mechanisms responsible for monocyte-to-macrophage differentiation and, subsequently, the effect of metformin in regressing angiotensin II (Ang-II)-mediated atheromatous plaque formation in ApoE−/− mice. AMPK activity was dose and time dependently downregulated during phorbol myristate acetate (PMA)-induced monocyte-to-macrophage differentiation, which was accompanied by an upregulation of proinflammatory cytokine production. Of note, AMPK activators metformin and AICAR significantly attenuated PMA-induced monocyte-to-macrophage differentiation and proinflammatory cytokine production. However, inhibition of AMPK activity alone by compound C was ineffective in promoting monocyte-to-macrophage differentiation in the absence of PMA. On the other hand, inhibition of c-Jun N-terminal kinase activity inhibited PMA-induced inflammation but not differentiation, suggesting that inflammation and differentiation are independent events. In contrast, inhibition of STAT3 activity inhibited both inflammation and monocyte-to-macrophage differentiation. By decreasing STAT3 phosphorylation, metformin and AICAR through increased AMPK activation caused inhibition of monocyte-to-macrophage differentiation. Metformin attenuated Ang-II–induced atheromatous plaque formation and aortic aneurysm in ApoE−/− mice partly by reducing monocyte infiltration. We conclude that the AMPK-STAT3 axis plays a pivotal role in regulating monocyte-to-macrophage differentiation and that by decreasing STAT3 phosphorylation through increased AMPK activity, AMPK activators inhibit monocyte-to-macrophage differentiation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A working model of metformin’s anti-inflammatory properties also suggests that metformin, in an AMPK-dependent inhibition of STAT3, prevents the differentiation of monocytes to macrophages”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Vasamsetti et al. 2015
Citations
Cites
1 retracted
Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase
Wu, Y., Song, P., Xu, J., Zhang, M., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608310200 · Cited by 274 · cited 1×
“AMPK-mediated signaling events are downregulated by lipopolysaccharides (LPSs), free fatty acids, high-fat diets, and lipid infusion in macrophages and endothelial cells (12,13).”
BackgroundRetractedRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Earlier studies showed that the pleiotropic effects of metformin are partly mediated by the activation of AMPK (7,8).”
BackgroundAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602 · cited 2×
“AMPK functions as a fuel gauge, sensing the changes in the energy status of the cell and, thus, playing a critical role in regulating systemic energy balance (9,10).”
BackgroundKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“AMPK functions as a fuel gauge, sensing the changes in the energy status of the cell and, thus, playing a critical role in regulating systemic energy balance (9,10).”
BackgroundMacrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669 · cited 3×
“a diverse repertoire of inflammatory mediators (2).”
BackgroundThe immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182 · cited 3×
“Substantial evidence implicates that macrophages are abundantly present at all stages of atherosclerotic disease process (1).”
InfluentialPPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637 · cited 1×
“AMPK activity in the blood is predominantly located in monocytes and lymphocytes as the 1a isoform (25), and a reduction in AMPK activity is associated with various pathophysiological effects (26).”
BackgroundAngiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
Daugherty, A., Manning, M. W., & Cassis, L. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7818 · Cited by 1,368 · cited 1×
“44 mg/kg/day as described previously (16-18) for 6 weeks through sub-cutaneous route where as control group received normal saline.”
Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2074 · Cited by 806
Sag, D., Carling, D., Stout, R. D., & Suttles, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8633 · Cited by 796 · cited 7×
“Metformin-activated AMPK inhibited LPS-induced proinflammatory cytokine levels by inhibiting JNK1 phosphorylation in macrophages (28).”
InfluentialThe macrophage foam cell as a target for therapeutic intervention
Li, A. C., & Glass, C. K. (2002) · Nature Medicine · doi:10.1038/nm1102-1235 · Cited by 700 · cited 1×
“muscle cells from media to intima (2,3).”
Zang, M., Zuccollo, A., Hou, X., Nagata, D., Walsh, K., Herscovitz, H., Brecher, P., Ruderman, N. B., & Cohen, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408149200 · Cited by 453 · cited 1×
“Earlier studies showed that the pleiotropic effects of metformin are partly mediated by the activation of AMPK (7,8).”
BackgroundYang, Z., Kahn, B. B., Shi, H., & Xue, B.-Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123620 · Cited by 410
McLemore, M. L., Grewal, S., Liu, F., Archambault, A., Poursine-Laurent, J., Haug, J., & Link, D. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00101-7 · Cited by 209 · cited 1×
“Activation of STAT3 Is Involved in Monocyte-toMacrophage Differentiation and Inflammation STAT3 plays a role in regulating cellular differentiation, and AMPK negatively regulates STAT3 phosphorylation (23,24).”
BackgroundWoo, S.-L., Xu, H., Li, H., Zhao, Y., Hu, X., Zhao, J., Guo, X., Guo, T., Botchlett, R., Qi, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091111 · Cited by 194 · cited 1×
“Metformin-activated AMPK inhibited LPS-induced proinflammatory cytokine levels by inhibiting JNK1 phosphorylation in macrophages (28).”
BackgroundGavrila, D., Li, W. G., McCormick, M. L., Thomas, M., Daugherty, A., Cassis, L. A., Miller, F. J., Oberley, L. W., Dellsperger, K. C., & Weintraub, N. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000172631.50972.0f · Cited by 175
Abbasi, F., Chu, J. W., McLaughlin, T., Lamendola, C., Leary, E. T., & Reaven, G. M. (2004) · Metabolism · doi:10.1016/j.metabol.2003.07.020 · Cited by 163 · cited 1×
“tions in addition to glycemic control (4).”
Lindholm, C. R., Ertel, R. L., Bauwens, J. D., Schmuck, E. G., Mulligan, J. D., & Saupe, K. W. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0199-2 · Cited by 136 · cited 1×
“AMPK activity in the blood is predominantly located in monocytes and lymphocytes as the 1a isoform (25), and a reduction in AMPK activity is associated with various pathophysiological effects (26).”
BackgroundLee, W. J., Lee, I. K., Kim, H. S., Kim, Y. M., Koh, E. H., Won, J. C., Han, S. M., Kim, M.-S., Jo, I., Oh, G. T., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000190667.33224.4c · Cited by 136
Nerstedt, A., Johansson, A., Andersson, C. X., Cansby, E., Smith, U., & Mahlapuu, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1856-z · Cited by 106 · cited 2×
“STAT3 plays a role in regulating cellular differentiation and also AMPK negatively regulates STAT3 phosphorylation (23, 24).”
Mullugeta, Y., Chawla, R., Kebede, T., & Worku, Y. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0225-8 · Cited by 95 · cited 1×
“Metformin has been shown to improve the lipid profile by reducing LDL cholesterol as well as triglyceride levels in type 2 diabetic patients (29,30).”
BackgroundSakamoto, H., Aikawa, M., Hill, C. C., Weiss, D., Taylor, W. R., Libby, P., & Lee, R. T. (2001) · Circulation · doi:10.1161/hc2701.091070 · Cited by 93 · cited 1×
“Metformin Inhibits PMA-Induced Monocyte-toMacrophage Differentiation in THP-1 Monocytes PMA-induced THP-1 monocyte differentiation is a wellaccepted in vitro model for studying the monocyte-tomacrophage differentiation process (19).”
BackgroundMetformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes
Matsumoto, K., Sera, Y., Abe, Y., Tominaga, T., Yeki, Y., & Miyake, S. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.11.007 · Cited by 90 · cited 1×
“reported that metformin in diabetic patients significantly attenuates the progression of carotid artery intima-media thickness, a known index of atherosclerotic progression (6).”
BackgroundLi, Y., Xu, S., Jiang, B., Cohen, R. A., & Zang, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067532 · Cited by 71 · cited 1×
“Vascular suppression of AMPK stimulates arterial deposition of excess lipids, resulting in the development of atherosclerotic lesions (27).”
BackgroundIL-1R–Associated Kinase-1 Mediates Protein Kinase Cδ-Induced IL-1β Production in Monocytes
Tiwari, R. L., Singh, V., Singh, A., & Barthwal, M. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002526 · Cited by 46 · cited 2×
“Activation of c-Jun N-terminal kinase (JNK) plays a central role in IL-1β induction during monocyte differentiation (22).”
Strobilocercus fasciolaris infection with hepatic sarcoma and gastroenteropathy in a Wistar colony
Kumar, J. M., Reddy, P. L., Aparna, V., Srinivas, G., Nagarajan, P., Venkatesan, R., Sreekumar, C., & Sesikaran, B. (2006) · Veterinary Parasitology · doi:10.1016/j.vetpar.2006.05.029 · Cited by 36
Self-citationNamgaladze, D., Kemmerer, M., von Knethen, A., & Brüne, B. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt073 · Cited by 33 · cited 1×
“Induction of PPAR-γ expression and LPL activity is a common feature during monocyte and adipocyte differentiation (20, 21).”
Gopal, K., Nagarajan, P., Jedy, J., Raj, A. T., Kalai Gnanaselvi, S., Jahan, P., Sharma, Y., Shankar, E. M., & Kumar, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067098 · Cited by 32 · cited 1×
“44 mg/kg/day as described previously (16-18) for 6 weeks through sub-cutaneous route where as control group received normal saline.”
Self-citationYu, W., Liu‐Bryan, R., Stevens, S., Damanahalli, J. K., & Terkeltaub, R. A. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.04.001 · Cited by 26 · cited 2×
“In addition, decreased AMPK activity with increased STAT3 in smooth muscle cells has been shown to promote receptor for advanced glycation end product signaling–induced neointima formation in response to arterial injury (15).”
Background
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
The mechanisms of action of metformin
Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287
“Metformin has, for example, been shown to have direct effects on inflammation, including effects on NF-κB signalling and differentiation of monocytes into macrophages [52, 53], as well as suppressing proinflammatory cytokines from these macrophages.”
BackgroundThe Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Abdominal aortic aneurysm: update on pathogenesis and medical treatments
Golledge, J. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0114-9 · Cited by 788
Metadata
- Authors
- Vasamsetti, S. B., Karnewar, S., Kanugula, A. K., Thatipalli, A. R., Kumar, J. M., & Kotamraju, S.
- Affiliations
- Indian Institute of Chemical Technology (IN)
- Centre for Cellular and Molecular Biology (IN)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-12-31
- Volume
- 64
- Issue
- 6
- Pages
- 2028-2041
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2031565266
- Cited by
- 397
- References
- 32
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 32 · 2023: 42 · 2022: 38 · 2021: 63 · 2020: 45 · 2019: 35 · 2018: 37 · 2017: 25 · 2016: 25 · 2015: 12
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Engineering Research Board (F.NO.SR/SO/HS-110/2008)
- Council for Scientific and Industrial Research (EpiHeD-BSC-0118, SMiLE-CSC-0111)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metformin, monocyte-to-macrophage differentiation, AMPK, STAT3 phosphorylation, atherosclerosis, angiotensin II, inflammatory cytokines, c-Jun N-terminal kinase, aortic aneurysm, ApoE-deficient mice, AICAR, macrophage polarization, inflammation
- MeSH terms
- Animals, Apolipoproteins E, Cell Differentiation, Macrophages, Male, Metformin, Monocytes, Polymethacrylic Acids, Mice, Knockout, Atherosclerosis, STAT3 Transcription Factor, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.